Tissue Repair Ltd (AU:TRP) has released an update.
Tissue Repair Ltd (ASX:TRP) is set to rejuvenate its leadership with the appointment of Alistair McKeough and Patryk Kania as Non-Executive Directors, effective after the upcoming Annual General Meeting. This strategic move aims to leverage Kania’s extensive experience in medical device commercialization and McKeough’s legal expertise to enhance the company’s clinical and commercial strategies. The board changes come as TRP focuses on advancing phase 3 trials for its promising wound healing agent, TR-987®, and further commercializing its innovative skincare products.
For further insights into AU:TRP stock, check out TipRanks’ Stock Analysis page.